In an oxidative ER environment, activated ERO1 generates disulfide bonds by consuming O 2 in the presence of flavin cofactors, which are then passed to the protein for folding via PDI (Wang et al., 2014)
Structural Comparison with Tirzepatide# The structural relationship between retatrutide and tirzepatide warrants detailed comparison, as both are multi-receptor incretin agonists developed by Eli Lilly: The most pharmacologically consequential structural difference is the engineering of glucagon receptor agonism into retatrutide
These side effects can typically be managed by reducing the L-carnitine dose or by taking oral metronidazole, a medicine that can reduce the overgrowth of bacteria in the intestines
The dosing requirements also vary between orforglipron and oral semaglutide
Zhang HS, Li HY, Zhou Y, Wu MR, Zhou HS